Safety and efficacy of recombinant activated factor VII in nonhemophilia children with severe or life-threatening bleeding: a report from the SeveNBleeP registry

Grants

Funding Acknowledgements

The SeveNBleeP registry is sponsored by Masaryk University. Masaryk University had no role in the collection or processing of registry data, and had no influence on the management of the registry. From 2005 to 2009, SeveNBleeP registry was endorsed by the Perinatal/Paediatric Subcommittee of SSC ISTH.